This is the product title

NMNH (Reduced NMN) - Product


Place of Origin : Shanghai,China

Product Description

World's First, Largest, and Longest Human Clinical Trial on NMNH (Reduced NMN)
Product Name: ß-Nicotinamide Mononucleotide, reduced form (NMNH)
CAS No. : 4229-56-5

Physical Specification

Other Specification : 

Phase I Clinical Trial Result Has Shown UthPeak® NMNH (Reduced NMN) Effects On

3X NAD+ INCREMENT

Years YOUGNER

35% Boost In ENERGY

31% Improvement In EMOTIONAL WELLNESS

UthPeak® Has Recently Obtained The Self-affirmed GRAS Status For Use In Selected Conventional Foods, cellular Health Supplements, and Medical Foods.

Why UthPeak® NMNH

Preclinical And Clinical Studies To Ensure Safety And Efficacy

EffePharm Has Been Dedicated To Delivering Safe And Clinically-backed Ingredients top Nmn Supplements. To Ensure The Safety Of UthPeak® NMNH, Comprehensive Preclinical Toxicology Studies Have Been Conducted. UthPeak® Is The First NMNH Brand Globally To Conduct The Largest And Longest Human Clinical Trial On NMNH (reduced NMN).



Company Inforamtion
EffePharm Ltd.
[ Manufacturer - China ]
 : Bld 4, No.1, Mid Wangdong Rd,Chongming District Shanghai, China 201601
 : 86-021 5770 9202
 : effepharm1018@gmail.com
 : effepharm.com/

 : Irene Liu
 : 86-021 5770 9202
 : effepharm1018@gmail.com
View Profile



Top 3 in Health and Medical



Top Products of EffePharm Ltd.